Permanence Bio is developing therapeutics that act at the root of disease by preventing DNA damage, which is a major driver of cancer and aging. Their approach incorporates a high-throughput screening platform and artificial intelligence for the discovery of genome-stabilizing therapies.

Permanence Bio is developing therapeutics that act at the root of disease by preventing DNA damage, which is a major driver of cancer and aging. Their approach incorporates a high-throughput screening platform and artificial intelligence for the discovery of genome-stabilizing therapies.